Renaissance Technologies (RenTech)'s DTIL Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 68,577 shares of Precision BioSciences, Inc. (DTIL) worth $539,015, representing 0.00% of the portfolio. First purchased in 2020-Q1, this long-term strategic position has been held for 25 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in DTIL, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 130,300 shares. Largest reduction occurred in Q2 2026, reducing 154,600 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Precision BioSciences (DTIL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Precision BioSciences (DTIL) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -154,600 | Reduce 69.27% | 68,577 | $7.86 |
| Q1 2026 | -103,300 | Reduce 31.64% | 223,177 | $5.50 |
| Q4 2025 | +130,300 | Add 66.42% | 326,477 | $4.16 |
| Q3 2025 | +115,900 | Add 144.38% | 196,177 | $5.52 |
| Q2 2025 | -2,700 | Reduce 3.25% | 80,277 | $4.20 |
| Q1 2025 | -26,821 | Reduce 24.43% | 82,977 | $4.77 |
| Q4 2024 | +29,200 | Add 36.23% | 109,798 | $3.81 |
| Q3 2024 | -2,400 | Reduce 2.89% | 80,598 | $8.96 |
| Q2 2024 | -16,500 | Reduce 16.58% | 82,998 | $9.73 |
| Q1 2024 | +13,124 | Add 15.19% | 99,498 | $13.56 |
| Q4 2023 | +33,305 | Add 62.76% | 86,374 | $10.95 |
| Q3 2023 | -4,153 | Reduce 7.26% | 53,069 | $10.23 |
| Q2 2023 | +6,344 | Add 12.47% | 57,222 | $0.02 |
| Q1 2023 | -1,813 | Reduce 3.44% | 50,878 | $0.02 |
| Q4 2022 | -19,731 | Reduce 27.24% | 52,691 | $0.04 |
| Q3 2022 | +42,196 | Add 139.60% | 72,422 | $38.99 |
| Q2 2022 | +22,447 | Add 288.56% | 30,226 | $48.01 |
| Q1 2022 | +7,099 | Add 1043.97% | 7,779 | $92.43 |
| Q4 2021 | +680 | New Buy | 680 | $222.06 |
| Q3 2021 | -3,371 | Sold Out | 0 | $0.00 |
| Q2 2021 | -844 | Reduce 20.02% | 3,371 | $375.56 |
| Q1 2021 | +2,977 | Add 240.47% | 4,215 | $310.56 |
| Q4 2020 | +1,238 | New Buy | 1,238 | $250.40 |
| Q2 2020 | -2,988 | Sold Out | 0 | $0.00 |
| Q1 2020 | +2,988 | New Buy | 2,988 | $181.06 |
Renaissance Technologies (RenTech)'s Precision BioSciences Investment FAQs
Renaissance Technologies (RenTech) first purchased Precision BioSciences, Inc. (DTIL) in Q1 2020, acquiring 2,988 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Precision BioSciences, Inc. (DTIL) for 25 quarters since Q1 2020.
Renaissance Technologies (RenTech)'s largest addition to Precision BioSciences, Inc. (DTIL) was in Q4 2025, adding 326,477 shares worth $1.36 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 68,577 shares of Precision BioSciences, Inc. (DTIL), valued at approximately $539,015.
As of the Q2 2026 filing, Precision BioSciences, Inc. (DTIL) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Precision BioSciences, Inc. (DTIL) was 326,477 shares, as reported at the end of Q4 2025.